tldr - powered by Generative AI

• Drug development is becoming more challenging and expensive due to the high failure rate of experiments.
• Insitro is using high-quality data and machine learning models to predict the outcome of experiments and design novel therapies.
• The focus is on learning meaningful representations of clinical state using self-supervised machine learning models.
• Insitro has partnered with pharmaceutical companies to access data on liver disease and used machine learning to predict patient progression.
• The ultimate goal is to develop a new approach to drug development that helps more people faster and at a lower cost.